Pharmacyclics, Inc.(NASDAQ : PCYC)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading PCYC News...
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||3.65%||62.53||0.6%||$770.31m|
|JNJ||Johnson & Johnson||-0.04%||114.15||0.7%||$598.50m|
|BMY||Bristol-Myers Squibb Company||-11.29%||49.23||0.7%||$554.17m|
|LLY||Eli Lilly and Company||-0.05%||76.80||1.0%||$325.59m|
|NVS||Novartis AG Sponsored ADR||0.31%||70.65||0.2%||$244.73m|
|AZN||AstraZeneca PLC Sponsored ADR||-3.01%||27.07||1.0%||$157.50m|
|GSK||GlaxoSmithKline plc Sponsored ADR||-0.08%||38.72||0.2%||$127.25m|
|SNY||Sanofi Sponsored ADR||0.55%||40.39||0.1%||$83.32m|
|NVO||Novo Nordisk A/S Sponsored ADR Class B||-0.25%||35.54||0.2%||$75.96m|
|LCI||Lannett Company, Inc.||0.65%||19.33||30.2%||$21.40m|
|SCMP||Sucampo Pharmaceuticals, Inc. Class A||-0.44%||11.40||15.0%||$13.03m|
|AKTX||Akari Therapeutics Plc Sponsored ADR||-6.63%||7.47||0.1%||$0.02m|
|EPIX||ESSA Pharma Inc||0.00%||2.02||0.0%||$0.01m|
Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.